Archives

by in
Entry Author Date Location
At U-M, 40 Years Of Gaucher Research Rewarded With FDA Approval 09/11/14 Detroit
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
Standing on a Ledge Once Again, Amicus Holds Breath for Latest Study 08/11/14 New York
Zurex Pharma Raises $4M to Battle Hospital-Acquired Infections 07/02/14 Wisconsin
Bluebird’s Gene Therapy Quickly Halts Blood Disease in Small Study 06/14/14 Boston
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
RNA Therapeutics Are Here to Stay 06/05/14 San Diego
In Need Of Revenues, Aastrom Buys Sanofi’s Cell Therapy Products 04/25/14 Detroit
AAVLife Gets $12M to Bring Gene Therapy to Rare Ataxia 04/15/14 Boston
Roundup: Aastrom, Gale, STEM summer camps, Beringea, HelloWorld 04/11/14 Detroit
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More 03/28/14 Boston
San Diego’s Connect Names Pharma Executive Greg McKee as CEO 03/04/14 San Diego
Hiring in Biotech is Tricky. But Algorithms Won’t Save the Day 02/24/14 National
Dicerna Shares Triple on First Trading Day, Close at $46 01/30/14 Boston
Gene Therapy Lurches Ahead, Sees Thorny Future Questions on Price 01/27/14 National
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
San Diego Life Sciences Roundup: Isis, Receptos, Suneva, and More 01/17/14 San Diego
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Alnylam Wheels, Deals, and Gets $700M Investment From Genzyme 01/13/14 Boston
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
Hologic Names New CEO, Cuts Deal With Icahn to Avoid Proxy Fight 12/09/13 Boston
Proteostasis, Biogen Team up on Protein Homeostasis Drugs 12/09/13 Boston
3 Life Sciences Companies That Are Built to Last 12/02/13 National
Hologic, Fending off Icahn, Adopts Poison Pill to Deflect Takeover 11/21/13 Boston
Dimension, Backed by Fidelity, Targets Hemophilia With Gene Therapy 10/31/13 Boston
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
The $100M Club: Where the Major League Life Sciences Companies Are 10/14/13 National
9 Takeaways from Boston’s Life Science Disruptors 10/04/13 Boston
Page 1 of 15 next page »